arrow
E

Esra Karabıber

Marmara University
H指数:6
被引数:166

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune Checkpoint Dysfunction Remodels Adaptive Immune Receptor Repertoires in CTLA-4 Insufficiency and LRBA Deficiency

免疫检查点功能障碍重塑CTLA-4不足和LRBA缺陷中的适应性免疫受体库

2026-10-190
PRE
Expansion of Myeloid-Derived Suppressor Cells and Lymphocyte Apoptosis Beyond B-Cell Deficiency in X-Linked Agammaglobulinemia

X-连锁无丙种球蛋白血症中,B细胞缺陷之外的髓系来源抑制性细胞扩增和淋巴细胞凋亡

2025-11-090
PRE
Monocyte plasticity and HLA-DR expression in patients with X-linked agammaglobulinemia

X连锁无丙种球蛋白血症患者中的单核细胞可塑性和HLA-DR表达

2025-09-190
PRE
Abatacept Restores Dysregulated Transcriptomic and Proteomic Profile in Disorders of CTLA-4 Insufficiency

阿巴西特能够恢复CTLA-4缺乏症的失调转录组学和蛋白质组学特征

2025-09-160
PRE
Insights into Patient Experiences with Facilitated Subcutaneous Immunoglobulin Therapy in Primary Immune Deficiency: A Prospective Observational Cohort

深入了解原发性免疫缺陷患者皮下免疫球蛋白治疗的经验: 前瞻性观察队列

2024-08-053
OAAI
GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway (vol 25, pg 282, 2024)

GIMAP5缺陷揭示了哺乳动物神经酰胺驱动的长寿保证途径 (第25卷,282页,2024页)

2024-02-120
OA
GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway

GIMAP5缺陷揭示了哺乳动物神经酰胺驱动的长寿保证途径

2024-01-037
PRE
Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency
2023-12-0115
PRE
Adverse COVID-19 outcomes in immune deficiencies: Inequality exists between subclasses
2021-08-1034
OAAI